{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T09:24:13Z","timestamp":1696411453740},"reference-count":47,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T00:00:00Z","timestamp":1470441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Facial lipoatrophy (<jats:styled-content style=\"fixed-case\">FLA<\/jats:styled-content>), characterized by a decrease in facial volume, has a high prevalence in patients with human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>) infection treated with long\u2010term highly active antiretroviral therapy (<jats:styled-content style=\"fixed-case\">HAART<\/jats:styled-content>). The social stigmatization that results from such changes in facial appearance has led some <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> patients to discontinue <jats:styled-content style=\"fixed-case\">HAART<\/jats:styled-content>. The use of fillers is one method of restoring facial volume. A critical outcome of treatment concerns the patient's quality of life (QoL). Although many studies have assessed patient satisfaction, as well as the social and psychological outcomes associated with the correction of <jats:styled-content style=\"fixed-case\">HIV FLA<\/jats:styled-content>, fewer studies have assessed QoL. We reviewed treatment options for <jats:styled-content style=\"fixed-case\">HIV FLA<\/jats:styled-content> with a specific focus on QoL outcomes. Our analysis revealed that the following treatments were associated with improvements in QoL: poly\u2010<jats:sc>l<\/jats:sc>\u2010lactic acid; calcium hydroxylapatite; hyaluronic acid; polyacrylamide gel; polyalkylamide gel; polymethylmethacrylate; silicone oil; and autologous fat transfer. The treatment of <jats:styled-content style=\"fixed-case\">HIV FLA<\/jats:styled-content> with these agents appears to improve QoL as assessed by various QoL instruments. Additional studies are required to identify a unifying QoL instrument to effectively assess longitudinal QoL outcomes and to compare treatment modalities.<\/jats:p>","DOI":"10.1111\/ijd.13374","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T12:00:22Z","timestamp":1470484822000},"page":"1311-1320","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quality of life outcomes associated with treatment of human immunodeficiency virus (HIV) facial lipoatrophy"],"prefix":"10.1111","volume":"55","author":[{"given":"Christina N.","family":"Kraus","sequence":"first","affiliation":[{"name":"School of Medicine Georgetown University Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance W.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California Irvine Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota Z.","family":"Korta","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California Irvine Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Zachary","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California Irvine Irvine CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,8,6]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm499"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.10.019"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2001.00359.x"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200212153-00011"},{"key":"e_1_2_5_6_1","first-page":"546","article-title":"Psychosocial impact of the lipodystrophy syndrome in HIV infection","volume":"10","author":"Collins E","year":"2000","journal-title":"AIDS Read"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2012.0214"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00694.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00315.2011"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350601100109"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833ea9bc"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.20.151"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00342.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318158bec9"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00667.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2006.20.829"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-92"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1090820X13515270"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12021"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.3.329"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2008.07.046"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0029"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2012.02474.x"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2011.11.024"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12358"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000234847.36020.52"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000148252"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182362142"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0042"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2007.0029"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3281c6148d"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540120902814379"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1310\/hct1206-323"},{"key":"e_1_2_5_34_1","first-page":"804","article-title":"Use of a biopolymer polyalkylimide filler for facial lipodystrophy in HIV\u2010positive patients undergoing treatment with antiretroviral drugs","volume":"32","author":"Treacy PJ","year":"2006","journal-title":"Dermatol Surg"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-008-9189-8"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009086"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12400"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1067\/moe.2002.124459"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30175.x"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.03.025"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-1298(20)31069-5"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2006.07.857"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.10.1220"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e31822e5cf8"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.08.040"},{"key":"e_1_2_5_46_1","first-page":"93","article-title":"HIV\u2010associated facial lipoatrophy \u2013 review of current therapy options","volume":"13","author":"Bechara FG","year":"2008","journal-title":"Eur J Med Res"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412474539"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018451930750"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.13374","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.13374","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.13374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T04:41:43Z","timestamp":1696308103000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.13374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,6]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1111\/ijd.13374"],"URL":"https:\/\/doi.org\/10.1111\/ijd.13374","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,6]]},"assertion":[{"value":"2016-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}